Literature DB >> 2324532

Porphyria cutanea tarda as initial presentation of the acquired immunodeficiency syndrome in two patients.

P Reynaud, K Goodfellow, F Svec.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2324532     DOI： 10.1093/infdis/161.5.1032

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Porphyria cutanea tarda and HIV infection: effect of zidovudine treatment on a patient.

Authors:  S Gafà; A Zannini; C Gabrielli
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

2.  Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.

Authors:  R D Levere; Y F Gong; A Kappas; D J Bucher; G P Wormser; N G Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C.

Authors:  J D Rich; E Mylonakis; R Nossa; R M Chapnick
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

4.  Porphyria cutanea tarda in a human immunodeficiency virus-infected patient: A rare scenario in India.

Authors:  Ramesh M Bhat; Malcolm Pinto; S Dandakeri; Srinath M Kambil
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014-01

5.  Hepatitis C- and HIV-induced porphyria cutanea tarda.

Authors:  Raphael Quansah; Chad J Cooper; Sarmad Said; Jorge Bizet; David Paez; German T Hernandez
Journal:  Am J Case Rep       Date:  2014-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.